Ocular surface reconstruction: Recent innovations, surgical candidate selection and postoperative management

Expert Review of Ophthalmology

Volumn 3, Issue 5, 2008, Pages 567-584

  Nguyen, Pho ^a   Yiu, Samuel C ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DOHENY EYE INSTITUTE   (United States)

Author keywords

Amniotic membrane; Limbal stem cell transplant; Ocular surface reconstruction; Patient management; Prosthesis

Indexed keywords

ANTIBIOTIC AGENT; ARTIFICIAL TEAR; CORTICOSTEROID; CYCLOSPORIN A; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MACROGOL; POLY(METHYL METHACRYLATE); POLYACRYLIC ACID; POLYCAPROLACTONE;

AMNION; BIOARTIFICIAL ORGAN; BLINDNESS; CONJUNCTIVA DISEASE; CONTACT LENS; CORNEA DISEASE; CORNEA SURGERY; CORNEA TRANSPLANTATION; CYTOLOGY; DRY EYE; EMBRYONIC STEM CELL; EPITHELIUM CELL; EYE SURGERY; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HOMEOSTASIS; HUMAN; KERATOPLASTY; LACRIMAL GLAND FUNCTION; LIMBAL STEM CELL TRANSPLANTATION; MEDICAL RESEARCH; MESENCHYMAL STEM CELL TRANSPLANTATION; MORBIDITY; NONHUMAN; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE CARE; REGENERATIVE MEDICINE; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; STEVENS JOHNSON SYNDROME; SURGICAL TECHNIQUE; TISSUE ENGINEERING; VISUAL PROSTHESIS;

EID: 69949173164     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/17469899.3.5.567     Document Type: Review

References (181)

1. Yiu SC, Thomas P, Nguyen P. Ocular surface reconstruction: recent advances and future outlook. Curr. Opin. Ophthalmol. 18(6), 509-514 (2007).
2. Di Pascuale MA, Espana EM, Liu DT et al. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens - Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112(5), 904-912 (2005).
3. Cher I. Blink-related microtrauma: when the ocular surface harms itself. Clin. Experiment. Ophthalmol. 31(3), 183-190 (2003).
4. Tsubota K, Hata S, Okusawa Y, Eqami F, Ohtsuki T, Nakamori K. Quantitative videographic analysis of blinking in normal subjects and patients with dry eye. Arch. Ophthalmol. 114(6), 715-720 (1996).
5. Nelson JD. Diagnosis of keratoconjunctivitis sicca. Int. Ophthalmol. Clin. 34(1), 37-56 (1994).
6. Tsubota K, Toda I, Yagi Y, Ogawa Y, Ono M, Yoshino K. Three different types of dry eye syndrome. Cornea 13(3), 202-209 (1994).
7. Murillo-Lopez F, Pflugfelder SC. Cornea and External Disease: Clinical Diagnosis and Management, Volume II. Murillo-Lopez F, Pflugfelder SC (Eds). Mosby, MO, USA 663-686 (1997).
8. Patel S, Blades K. The Dry Eye: A Practical Approach. Butterworth-Heinemann, Scotland (2003).
9. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 21(4), 221-232 (1995).
10. Pfister RR. Corneal stem cell disease: concepts, categorization, and treatment by auto- and homotransplantation of limbal stem cells. CLAO J. 20(1), 64-72 (1994).
11. Schermer A, Galvin S, Sun TT. Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J. Cell Biol. 103(1), 49-62 (1986).
12. Puangsricharern V, Tseng SC. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology 102(10), 1476-1485 (1995).
13. Tsubota K, Toda I, Saito H, Shinozaki N, Shimazaki J. Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology 102(10), 1486-1496 (1995).
14. Thoft RA. Conjunctival transplantation. Arch. Ophthalmol. 95(8), 1425-1427 (1977).
15. Thoft RA. Keratoepithelioplasty. Am. J. Ophthalmol. 97(1), 1-6 (1984).
16. Kenyon KR, Tseng SC. Limbal autograft transplantation for ocular surface disorders. Ophthalmology 96(5), 709-722 (1989).
17. Kenyon KR. Limbal autograft transplantation for chemical and thermal burns. Dev. Ophthalmol. 18, 53-58 (1989).
18. Copeland RA Jr, Char DH. Limbal autograft reconstruction after conjunctival squamous cell carcinoma. Am. J. Ophthalmol. 110(4), 412-415 (1990).
19. Mashima Y, Yamada M, Yamada H, Tsunoda K Arimoto M. Limbal autograft transplantations for chronic ocular surface failure [Japanese]. Jpn. J. Clin. Ophthalmol. 47, 607-610 (1993).
20. Tsai RJ, Tseng SCG. Human allograft limbal transplantation for corneal surface reconstruction. Cornea 13(5), 389-400 (1994).
21. Sangwan VS, Vemuganti GK, Singh S, Balasubramanian D. Successful reconstruction of damaged ocular outer surface in humans using limbal and conjunctival stem cell culture methods. Biosci. Reports 23(4), 169-174 (2004).
22. Kim JC, Tseng SCG. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14(5), 473-484 (1995).
23. Kwitko S, Raminho D, Barcaro S et al. Allograft conjunctival transplantation for bilateral ocular surface disorders. Ophthalmology 102(7), 1020-1025 (1995).
24. Tan DTH, Ficker LA, Buckley RJ. Limbal transplantation. Ophthalmology 103(1), 29-36 (1996).
25. Morgan S, Murray A. Limbal autotransplantation in the acute and chronic phases of severe chemical injuries. Eye 10(Pt 3), 349-354 (1996).
26. Pellegrini G, Traverso CE, Franzi AT, Zingirian M, Cancedda R, De Luca M. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 349(9057), 990-993 (1997).
27. Tseng SC, Tsubota K. Important concepts for treating ocular surface and tear disorders. Am. J. Ophthalmol. 124(6), 825-835 (1997).
28. Theng JTS, Tan DTH. Combined penetrating keratoplasty and limbal allograft transplantation for severe corneal burns. Ophthalmic Surg. Lasers 28(9), 765-768 (1997).
29. Tsubota K, Satake Y, Kaido M et al. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N. Engl. J. Med. 340(22), 1697-1703 (1999).
30. Azuara-Blanco A, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br. J. Ophthalmol. 83(4), 399-402 (1999).
31. Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N. Engl. J. Med. 343(2), 86-93 (2000).
32. Schwab IR, Reyes M, Isseroff RR. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. Cornea 19(4), 421-426 (2000).
33. Holland EJ, Schwartz GS. Changing concepts in the management of severe ocular surface disease over twenty-five years. Cornea 19(5), 688-698 (2000).
34. Tseng SC. Significant impact of limbal epithelial stem cells. Indian J. Ophthalmol. 48(2), 79-81 (2000).
35. Daya SM, Ilari FA. Living related conjunctival limbal allograft for the treatment of stem cell deficiency. Ophthalmology 108(1), 126-134 (2001).
36. Rama P, Bonini S, Lambiase A et al. Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation 72(9), 1478-1485 (2001).
37. Gomes JA, dos Santos MS, Cunha MC, Mascaro VL, de Nadai Barros J, de Sousa LB. Amniotic membrane transplantation for partial and total limbal stem cell deficiency secondary to chemical burn. Ophthalmology 110(3), 466-473 (2003).
38. Nakamura T, Yoshitani M, Rigby H et al. Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Invest. Ophthalmol. Vis. Sci. 45(1), 93-94 (2004).
39. Tanioka H, Kawasaki S, Yamasaki K et al. Establishment of a cultivated human conjunctival epithelium as an alterative tissue source for autologous corneal epithelial transplantation. Invest. Ophthalmol. Vis. Sci. 47(9), 3820-3827 (2006).
40. Ang LP, Sotozono C, Koizumi N, Suzuki T, Inatomi T, Kinoshita S. A comparison between cultivated and conventional limbal stem cell transplantation for Stevens - Johnson syndrome. Am. J. Ophthalmol. 143(1), 178-180 (2007).
41. Higa K, Shimmura S, Kato N et al. Proliferation and differentiation of transplantable rabbit epithelial sheets engineered with or without an amniotic membrane carrier. Invest. Ophthalmol. Vis. Sci. 48(2), 597-615 (2007).
42. Shimazaki J, Maruyama F, Shimmura S, Fujishima H, Tsubota K. Immunologic rejection of the central graft after limbal allograft transplantation combined with penetrating keratoplasty. Cornea 20(2), 149-152 (2001).
43. Kruse FE, Chen JJ, Tsai RJ, Tseng SC. Conjunctival transdifferentiation is due to the incomplete removal of limbal basal epithelium. Invest. Ophthalmol. Vis. Sci. 31(9), 1903-1913 (1990).
44. Chen JJY, Tseng SCG. Abnormal corneal epithelial wound healing in partial-thickness removal of limbal epithelium. Invest. Ophthalmol. Vis. Sci. 32(8), 2219-2233, (1991).
45. Huang AJ, Tseng SC. Corneal epithelial wound healing in the absence of limbal epithelium. Invest. Ophthalmol. Vis. Sci. 32(1), 96-105 (1991).
46. Jenkins C, Tuft S, Liu C, Buckley R. Limbal transplantation in the management of chronic contact-lens-associated epitheliopathy. Eye 7, 629-633 (1993).
47. Nguyen DQ, Srinivasan S, Hiscott P, Kaye S. Thimerosal-induced limbal stem cell failure: report of a case and review of the literature. Eye Contact Lens 33(4), 196-198 (2007).
48. Dua HS, Azuara-Blanco A. Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency. Br. J. Ophthalmol. 84, 273-278 (2000).
49. Grueterich M, Espana EM, Touhami A, Ti SE, Tseng SCG. Phenotypic study of a case with successful transplantation of ex vivo expanded human limbal epithelium for unilateral total limbal stem cell deficiency. Ophthalmology 109(8), 1547-1552 (2002).
50. Tsubota K, Satake Y, Ohyama M et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens - Johnson syndrome. Am. J. Ophthalmol. 122(1), 38-52 (1996).
51. Tseng SC, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch. Ophthalmol. 116, 431-441 (1998).
52. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br. J. Ophthalmol. 82, 235-240 (1998).
53. Meller D, Pires RF, Tseng SC. Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures. Br. J. Ophthalmol. 86(4), 463-471 (2002).
54. Shimazaki J, Konomi K, Shimmura S, Tsubota K. Ocular surface reconstruction for thermal burns caused by fireworks. Cornea 25(2), 139-145 (2006).
55. Shimazaki J, Aiba M, Goto E, Kato N, Shimmura S, Tsubota K. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology 109(7), 1285-1290 (2002).
56. Inatomi T, Nakamura T, Kojyo M, Koizumi N, Sotozono C, Kinoshita S. Ocular surface reconstruction with combination of cultivated autologous oral mucosal epithelial transplantation and penetrating keratoplasty. Am. J. Ophthalmol. 142(5), 757-764 (2006).
57. Shimazaki J, Shimmura S, Fujishima H, Tsubota K. Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. Ophthalmology 107(8), 1518-1523 (2000).
58. Shimazaki J, Higa K, Morito F et al. Factors influencing outcomes in cultivated limbal epithelial transplantation for chronic cicatricial ocular surface disorders. Am. J. Ophthalmol. 143(6), 945-953 (2007).
59. Nakamura T, Inatomi T, Sotozono C, Amemiya T et al. Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders. Br. J. Ophthalmol. 88(10), 1280-1284 (2004).
60. Sangwan VS, Matalia HP, Vemuganti GK et al. Clinical outcome of autologous cultivated limbal epithelium transplantation. Indian J. Ophthalmol. 54, 29-34 (2006).
61. Kawashima M, Kawakita T, Satake Y, Higa K, Shimazaki J. Phenotypic study after cultivated limbal epithelial transplantation for limbal stem cell deficiency. Arch. Ophthalmol. 125(10), 1337-1344 (2007).
62. Inatomi T, Nakamura T, Koizumi N, Sotozono C et al. Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation. Am. J. Ophthalmol. 141(2), 267-275 (2006).
63. Gruss JS, Jirsch DW. Human amniotic membrane: a versatile wound dressing. Can. Med. Assoc. J. 118(10), 1237-1246 (1978).
64. Matthews RN, Bennett JP, Faulk WP. Wound healing using amniotic membranes. Br. J. Plast. Surg. 34(1), 76-78 (1981).
65. Ramakrishnan KM, Jayaraman V. Management of partial-thickness burn wounds by amniotic membrane: a cost-effective treatment in developing countries. Burns 23(Suppl. 1), S33-S36 (1997).
66. John T, Foulks G, John ME, Cheng K, Hu D. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. Ophthalmology 109(2), 351-360 (2002).
67. De Rotth A. Plastic repair of conjunctival defects with fetal membrane. Arch. Ophthalmol. 23, 522-525 (1940).
68. Dua HS, Gomes JA, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv. Ophthalmol. 49(1), 51-77 (2004).
69. Solomon A, Rosenblatt M, Monroy D, Ji Z, Pflugfelder SC, Tseng SCG. Suppression of interleukin 1α and interleukin 1β in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br. J. Ophthalmol. 85(4), 444-449 (2001).
70. Koizumi N, Inatomi T, Sotozono C, Fullwood NJ, Quantock AJ, Kinoshita S. Growth factor mRNA and protein in preserved human amniotic membrane. Curr. Eye Res. 20(3), 173-177 (2000).
71. Kim JS, Kim JC, Na BK, Jeong JM, Song CY. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp. Eye Res. 70(3), 329-337 (2000).
72. Park WC, Tseng SCG. Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest. Ophthalmol. Vis. Sci. 41(10), 2906-2914 (2000).
73. Tseng SCG, Li DQ, Ma X. Suppression of transforming growth factor-β isoforms, TGF-β receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J. Cell Physiol. 179(3), 325-335 (1999).
74. Lee SB, Li DQ, Tan DT, Meller DC, Tseng SCG. Suppression of TGF-β signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr. Eye Res. 20(4), 325-334 (2000).
75. Koizumi N, Inatomi T, Quantock A, Fullwood NJ, Dota A, Kinoshita S. Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea 19(1), 65-71 (2000).
76. Nakamura T, Inatomi T, Sekiyama E, Ang L, Yokoi N, Kinoshita S. Novel clinical application of sterilized, freeze-dried amniotic membrane to treat patients with pterygium. Acta Ophthalmol. Scand. 84(3), 401-405 (2006).
77. Hick S, Demers PE, Brunette I, La C, Mabon M, Duchesne B. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea 24(4), 369-377 (2005).
78. Ainsworth G, Rotchford A, Dua HS, King A J. A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery. Br. J. Ophthalmol. 90(4), 417-419 (2006).
79. Wylegala E, Tarnawska D. Amniotic membrane transplantation with cauterization for keratoconus complicated by persistent hydrops in mentally retarded patients. Ophthalmology 113(4), 561-564 (2006).
80. Luanratanakorn P, Ratanapakorn T, Suwan-Apichon O, Chuck RS. Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision. Br. J. Ophthalmol. 90(12), 1476-1480 (2006).
81. Espana EM, Prabhasawat P, Grueterich M, Solomon A, Tseng SC. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br. J. Ophthalmol. 86(6), 640-645 (2002).
82. Gündüz K, Uçakhan ÖÖ, Kanpolat A, Günalp I. Nonpreserved human amniotic membrane transplantation for conjunctival reconstruction after excision of extensive ocular surface neoplasia. Eye 20(3), 351-357 (2006).
83. Tomita M, Goto H, Muramatsu R, Usui M. Treatment of large conjunctival nevus by resection and reconstruction using amniotic membrane. Graefes Arch. Clin. Exp. Ophthalmol. 244(6), 761-764 (2006).
84. Ang LP, Chua JL, Tan DT. Current concepts and techniques in pterygium treatment. Curr. Opin. Ophthalmol. 18(4), 308-313 (2007).
85. Chen HJ, Pires RT, Tseng SC. Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br. J. Ophthalmol. 84(8), 826-833 (2000).
86. Ivekovic B, Tedeschi-Reiner E, Petric I, Novak-Laus K, Bradic-Hammoud M. Amniotic membrane transplantation for ocular surface reconstruction in neurotrophic corneal ulcers. Coll. Antropol. 26(1), 47-54 (2002).
87. Khokhar S, Natung T, Sony P, Sharma N, Agarwal N, Vajpayee RB. Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial. Cornea 24(6), 654-660 (2005).
88. Barequet IS, Habot-Wilner Z, Keller N et al. Effect of amniotic membrane transplantation on the healing of bacterial keratitis. Invest. Ophthalmol. Vis. Sci. 49(1), 163-167 (2008).
89. Zhou SY, Chen JQ, Chen LS, Liu ZG, Huang T, Wang ZC. Long-term results of amniotic membrane transplantation for conjunctival surface reconstruction [Chinese]. Zhonghua Yan Ke Za Zhi 40(11), 745-749 (2004).
90. Tamhane A, Vajpayee RB, Biswas NR et al. Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns. Ophthalmology 112(11), 1963-1969 (2005).
91. Joseph A, Dua HS, King AJ. Failure of amniotic membrane transplantation in the treatment of acute ocular burns. Br. J. Ophthalmol. 85(9), 1065-1069 (2001).
92. Nubile M, Dua HS, Lanzini TEM et al. Amniotic membrane transplantation for the management of corneal epithelial defects: an in vivo confocal microscopic study. Br. J. Ophthalmol. 92(1), 54-60 (2008).
93. Resch MD, Schlotzer-Schrehardt U, Hofmann-Rummelt C et al. Adhesion structures of amniotic membranes integrated into human corneas. Invest. Ophthalmol. Vis. Sci. 47(5), 1853-1861 (2006).
94. Saw VPJ, Minassian D, Dart JKG et al. Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from the UK user group. Br. J. Ophthalmol. 91(8), 1042-1047 (2007).
95. Essex RW, Snibson GR, Daniell M, Tole DM. Amniotic membrane grafting in the surgical management of primary pterygium. Clin. Exp. Ophthalmol. 32(5), 501-504 (2004).
96. Tananuvat N, Martin T. The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea 23(5), 458-463 (2004).
97. Szurman P, Warga M, Grisanti S et al. Sutureless amniotic membrane fixation using fibrin glue for ocular surface reconstruction in a rabbit model. Cornea 25(4), 460-466 (2006).
98. Sekiyama E, Nakamura T, Kurihara E et al. Novel sutureless transplantation of bioadhesive-coated, freeze-dried amniotic membrane for ocular surface reconstruction. Invest. Ophthalmol. Vis. Sci. 48(4), 1528-1534 (2007).
99. Kheirkhah A, Li W, Casas V, Tseng SCG. Sutureless amniotic membrane transplantation. Expert Rev. Ophthalmol. 1(1), 49-62 (2006).
100. Solomon A, Espana EM, Tseng SC. Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 110(1), 93-100 (2003).
101. Tseng SC, Di Pascuale MA, Liu DT, Gao YY, Baradaran-Rafii A. Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology 112(5), 896-903 (2005).
102. Oberhansli C, Spahn B. Amniotic membrane transplantation for oculopalpebral and reconstructive surgery [French]. J. Fr. Ophthalmol. 28(7), 759-764 (2005).
103. Ang LP, Tan DT, Seah CJ, Beuerman RW. The use of human serum in supporting the in vitro and in vivo proliferation of human conjunctival epithelial cells. Br. J. Ophthalmol. 89(6), 748-752 (2005).
104. Nakamura T, Inatomi T, Sotozono C et al. Transplantation of autologous serum-derived cultivated corneal epithelial equivalents for the treatment of severe ocular surface disease. Ophthalmology 113(10), 1765-1772 (2006).
105. Nakamura T, Ang LP, Rigby H et al. The use of autologous serum in the development of corneal and oral epithelial equivalents in patients with Stevens - Johnson syndrome. Invest. Ophthalmol. Vis. Sci. 47(3), 909-916 (2006).
106. Ang LP, Nakamura T, Inatomi T et al. Autologous serum-derived cultivated oral epithelial transplants for severe ocular surface disease. Arch. Ophthalmol. 124(11), 1543-1551 (2006).
107. Chen YT, Li W, Hayashida Y, He H et al. Human amniotic epithelial cells as novel feeder layers for promoting ex vivo expansion of limbal epithelial progenitor cells. Stem Cells 25(8), 1995-2005 (2007).
108. Notara M, Haddow DB, MacNeil S, Daniels JT. A xenobiotic-free culture system for human limbal epithelial stem cells. Regen. Med. 2(6), 919-927 (2007).
109. Yokoo S, Yamagami S, Usui T, Amano S, Araie M. Human corneal epithelial equivalents for ocular surface reconstruction in a complete serum-free culture system without unknown factors. Invest. Ophthalmol. Vis. Sci. 49, 2438-2443 (2008).
110. Hopkinson A, McIntosh RS, Tighe PJ, James DK, Harminder SD. Amniotic membrane for ocular surface reconstruction: donor variations and the effect of handling on TGF-β content. Invest. Ophthalmol. Vis. Sci. 47(10), 4316-4322 (2006).
111. Maharajan VS, Shanmuganathan V, Currie A, Hopkinson A, Powell-Richards A, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction: indications and outcomes. Clin. Experiment. Ophthalmol. 35(2), 140-147 (2007).
112. Anderson SB, de Souza F, Hofmann-Rummelt C, Seitz B. Corneal calcification after amniotic membrane transplantation. Br. J. Ophthalmol. 87(5), 587-591 (2003).
113. Bernauer W, Thiel MA, Kurrer M et al. Corneal calcification following intensified treatment with sodium hyaluronate artificial tears. Br. J. Ophthalmol. 90(3), 285-288 (2006).
114. Nishida K, Yamato M, Hayashida Y et al. Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface. Transplantation 77(3), 379-385 (2004).
115. Nishida K, Yamato M, Hayashida Y et al. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N. Engl. J. Med. 351(12), 1187-1196 (2004).
116. Lai JY, Chen KH, Hsiue GH. Tissue-engineered human corneal endothelial cell sheet transplantation in a rabbit model using functional biomaterials. Transplantation 84(10), 1222-1232 (2007).
117. Oztürk E, Ergün MA, Oztürk Z et al. Chitosan-coated alginate membranes for cultivation limbal epithelial cells to use in the restoration of damaged corneal surfaces. Int. J. Artif. Organs. 29, 228 (2006).
118. Ma LH, Yu WT, Ma XJ. Preparation and characterization of novel sodium alginate/chitosan two ply composite membranes. J. Appl. Polym. Sci. 106(21), 394-399 (2007).
119. Lai JY, Hsiue GH. Functional biomedical polymers for corneal regenerative medicine. React. Funct. Polym. 67(11), 1284-1291 (2007).
120. Ang LP, Cheng ZY, Beuerman RW, Teoh SH, Zhu X, Tan DT. The development of a serum-free derived bioengineered conjunctival epithelial equivalent using an ultrathin poly(epsilon-caprolactone) membrane substrate. Invest. Ophthalmol. Vis. Sci. 47(1), 105-112 (2006).
121. Torbet J, Malbouyres M, Builles N et al. Orthogonal scaffold of magnetically aligned collagen lamellae for corneal stroma reconstruction. Biomaterials 28(29), 4268-4276 (2007).
122. Galal A, Perez-Santonja JJ, Rodriguez-Prats JL, Abad M, Alio J. Human anterior lens capsule as a biologic substrate for the ex vivo expansion of limbal stem cells in ocular surface reconstruction. Cornea 26(4), 473-478 (2007).
123. Di Girolamo N, Chui J, Wakefield D, Coroneo MT. Cultured human ocular surface epithelium on therapeutic contact lenses. Br. J. Ophthalmol. 91(4), 459-464 (2007).
124. Nguyen P, Yiu SC. Multi-agent pharmaceutical therapy for modulation of corneal allograft immunologic rejection. Curr. Insights. 18(6), 509-514 (2007).
125. Gipson IK, Geggel HS, Spurr-Michaud SJ. Transplant of oral mucosal epithelium to rabbit ocular surface wounds in vivo. Arch. Ophthalmol. 104(10), 1529-1533 (1986).
126. Kinoshita S, Nakamura T. Development of cultivated mucosal epithelial sheet transplantation for ocular surface reconstruction. Artif. Organs. 28(1), 22-27 (2004).
127. Nakamura T, Inatomi T, Cooper LJ, Rigby H, Fullwood NJ, Kinoshita S. Phenotypic investigation of human eyes with transplanted autologous cultivated oral mucosal epithelial sheets for severe ocular surface diseases. Ophthalmology 114(6), 1080-1088 (2007).
128. Homma R, Yoshikawa H, Takeno M et al. Induction of epithelial progenitors in vitro from mouse embryonic stem cells and application for reconstruction of damaged cornea in mice. Invest. Ophthalmol. Vis. Sci. 45(12), 4320-4326 (2004).
129. Ma Y, Xu Y, Xiao Z et al. Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells 24(2), 315-321 (2006).
130. Oh JY, Kim MK, Shin MS et al. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells 26(4), 1047-1055 (2008).
131. Doane MG, Dohlman CH, Bearse G. Fabrication of a keratoprosthesis. Cornea 15(2), 179-184 (1996).
132. Hicks CR, Crawford GJ, Dart JK et al. AlphaCor: clinical outcomes. Cornea 25(9), 1034-1042 (2006).
133. Hicks CR, Crawford GJ, Lou X et al. Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications. Eye 17(3), 385-392 (2003).
134. Hicks CR, Crawford GJ, Tan DT et al. Outcomes of implantation of an artificial cornea, AlphaCor: effects of prior ocular herpes simplex infection. Cornea 21(7), 685-690 (2002).
135. Myung D, Koh W, Bakri A et al. Design and fabrication of an artificial cornea based on a photolithographically patterned hydrogel construct. Biomed. Microdevices 9(6), 911-922 (2007).
136. Geerling G, MacLennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br. J. Ophthalmol. 88(11), 1467-1474 (2004).
137. Lagnado R, King AJ, Donald F, Dua HS. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br. J. Ophthalmol. 88(4), 464-465 (2004).
138. Weisbach V, Dietrich T, Kruse FE, Eckstein R, Cursiefen C. HIV and hepatitis B/C infections in patients donating blood for use as autologous serum eye drops. Br. J. Ophthalmol. 91(12), 1724-1725 (2007).
139. Tatlipinar S, Akpek E. Topical ciclosporin in the treatment of ocular surface disorders. Br. J. Ophthalmol. 89(10), 1363-1367 (2005).
140. Barber LD, Pflugfelder SC, Tauber J, Foulks GN. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology 112(10), 1790-1794 (2005).
141. Asbell PA, Lemp MA. Dry Eye Disease: The Clinician's Guide to Diagnosis and Treatment. Thieme Medical Publishers, NY, USA (2006).
142. Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a twenty-five-year review. Cornea 19(5), 644-649 (2000).
143. Pflugfelder SC. Antiinflammatory therapy for dry eye. Am. J. Ophthalmol. 137(2), 337-342 (2004).
144. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp. Eye Res. 82, 885-898 (2006).
145. Bisbee CA. Prolactin effects on ion transport across cultured mouse mammary epithelium. Am. J. Physiol. 240(3), C110-C115 (1981).
146. Bacman SR, Berra A, Sterin-Borda L, Borda ES. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Curr. Eye Res. 17(12), 1135-1142 (1998).
147. Mathers WD, Stovall D, Lane JA, Zimmerman MB, Johnson S. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea 17(4), 353-358 (1998).
148. Schechter J, Carey J, Wallace M, Wood R. Distribution of growth factors and immune cells are altered in the lacrimal gland during pregnancy and lactation. Exp. Eye Res. 71(2), 129-142 (2000).
149. Guo Z, Song D, Azzarolo AM et al. Autologous lacrimal-lymphoid mixed-cell reactions induce dacryoadenitis in rabbits. Exp. Eye Res. 71(1), 23-31 (2000).
150. Adeghate E, Draper CE, Singh J. Effects of ageing on changes in morphology of the rat lacrimal gland. Adv. Exp. Med. Biol. 506(Pt A), 103-107 (2002).
151. Beauregard C, Brandt PC, Chiou GCY. Induction of nitric oxide synthase and over-production of nitric oxide by interleukin-1β in cultured lacrimal gland acinar cells. Exp. Eye Res. 77(1), 109-114 (2003).
152. Selvam S, Nakamura T, Samant D et al. Impact of chronic stimulation with carbachol, histamine and serotonin on ion transport in a novel, chloride-secreting rabbit lacrimal acinar cell monolayer model. Presented at: 2007 Annual Meeting of the Association for Research in Vision and Ophthalmology. Fort Lauderdale, FL, USA, 30 April-4 May 2007.
153. Selvam S, Thomas PB, Gukasyan HJ et al. Transepithelial bioelectrical properties of rabbit acinar cell monolayers on polyester membrane scaffolds. Am. J. Physiol. Cell. Physiol. 293(4), C1412-C1419 (2007).
154. Selvam S, Thomas PB, Trousdale MD et al. Tissue-engineered tear secretory system: functional lacrimal gland acinar cells cultured on matrix protein-coated substrata. J. Biomed. Mater. Res. B Appl. Biomater. 80(1), 192-200 (2007).
155. Selvam S, Thomas PB, Yiu SC. Tissue engineering: current and future approaches to ocular surface reconstruction. Ocul. Surf. 4(3), 120-136 (2006).
156. Samson M, Nduaguba C, Baltatzis S, Foster CS. Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology 109(5), 862-868 (2002).
157. Holland EJ, Schwartz GS. Epithelial stem-cell transplantation for severe ocular surface disease [editorial]. N. Engl. J. Med. 340(22), 1752-1753 (1999).
158. Schwartz GS, Gomes JAP, Holland EJ. Preoperative staging of disease severity. In: Ocular Surface Disease Medical and Surgical Management. Holland EJ, Mannis MJ (Eds). Springer - Verlag, NY, USA, 158-167 (2002).
159. Yao YF, Inoue Y, Miyazaki D, Shimomura Y, Ohashi Y, Tano Y. Ocular resurfacing and alloepithelial rejection in a murine keratoepithelioplasty model. Invest. Ophthalmol. Vis. Sci. 36, 2623-2633 (1995).
160. Solomon A, Ellies P, Anderson DF et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 109(6), 1159-1166 (2002).
161. Reinhard T, Spelsberg H, Henke L et al. Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency. Ophthalmology 111(4), 775-782 (2004).
162. Tsubota K, Shimazaki J. Surgical treatment of children blinded by Stevens - Johnson syndrome. Am. J. Ophthalmol. 128(5), 573-581 (1999).
163. Dogru M, Karakaya H, Özçetin H et al. Tear function and ocular surface changes in keratoconus. Ophthalmology. 110(6), 1110-1118 (2003).
164. Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 108(3), 586-592 (2001).
165. Ozdemir M, Buyukbese MA, Cetinkaya A, Ozdemir G. Risk factors for ocular surface disorders in patients with diabetes mellitus. Diab. Res. Clin. Prac. 59(3), 195-199 (2003).
166. Dogru M, Nakagawa N, Tetsumoto K, Kafakami C, Yamamoto M. Ocular surface disease in atopic dermatitis. Jpn. J. Ophthalmol. 43(1), 53-57 (1999).
167. Ilari L, Daya SM. Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. Ophthalmology 109(7), 1278-1284 (2002).
168. Reinhard T, Sundmacher R, Spelsberg H, Althaus C. Homologous penetrating central limbo-keratoplasty (HPCLK) in bilateral limbal stem cell insufficiency. Acta Ophthalmol. Scand. 77(6), 663-667 (1999).
169. Reinhard T, Böhringer D, Enczmann J et al. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching. Eye 18(3), 269-277 (2004).
170. Sundmacher R, Reinhard T. Central corneolimbal transplantation under systemic ciclosporin A cover for severe limbal stem cell insufficiency. Graefes Arch. Clin. Exp. Ophthalmol. 234(Suppl. 1), S122-S125 (1996).
171. Djalilian AR, Bagheri MM, Schwartz GS et al. Keratolimbal allograft for the treatment of limbal stem cell deficiency. Presented at: Castroviejo Cornea Society Annual Meeting. Orlando, FL, USA, 23 October 1999.
172. Rao SK, Rajagopal R, Sitalakshmi G, Padmanabhan P. Limbal allografting from related live donors for corneal surface reconstruction. Ophthalmology 106(4), 822-828 (1999).
173. Daya SM. Living-related conjunctivo-limbal allograft (lr-CLAL) for the treatment of stem cell deficiency, an analysis of long-term outcome [abstract]. Ophthalmology. 106(Suppl.), 243 (1999).
174. Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. Ophthalmology 108(10), 1838-1844 (2001).
175. Mills RA, Coster DJ, Williams KA. Effect of immunosuppression on outcome measures in a model of rat limbal transplantation. Invest. Ophthalmol. Vis. Sci. 43(3), 647-655 (2002).
176. Joseph A, Raj D, Shanmuganathan V, Powell RJ, Dua HS. Tacrolimus immunosuppression in high-risk corneal grafts. Br. J. Ophthalmol. 91(1), 51-55 (2007).
177. Young AL, Rao SK, Cheng LL, Wong AK, Leung AT, Lam DS. Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience. Eye 16(3), 304-308 (2002).
178. Lam DS, Wong AK, Tham CC, Leung AT. The use of combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: a preliminary study. Eye 12(Pt 4), 615-618 (1998).
179. Rumelt S, Bersudsky V, Blum-Hareuveni T, Rehany U. Systemic cyclosporin A in high failure risk, repeated corneal transplantation. Br. J. Ophthalmol. 86(9), 988-992 (2002).
180. Nguyen P, Barte F, Kang K et al. A novel pharmaceutical management of immunogenic rejection following repeat penetrating keratoplasty in high-risk patients. Abstract. Presented at: 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology. Fort Lauderdale, FL, USA, 30 April-4 May 2008.
181. Uy HS, Chan PS, Ang RE. Topical bevacizumab and ocular surface neovascularization in patients with Stevens - Johnson syndrome. Cornea 27(1), 70-73 (2008).